Stryker Corp financial data

Symbol
SYK on NYSE
Industry
Surgical & Medical Instruments & Apparatus
Location
1941 Stryker Way, Portage, MI
State of incorporation
MI
Fiscal year end
December 31
Latest financial report
10-Q - Q2 2024 - Jul 31, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 161 % -5.9%
Quick Ratio 67.7 % -6.09%
Return On Equity 18.3 % +13.6%
Return On Assets 8.81 % +19.7%
Operating Margin 19.7 % +15.3%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 381M shares +0.34%
Entity Public Float 110B USD +54.6%
Weighted Average Number of Shares Outstanding, Basic 381M shares +0.34%
Weighted Average Number of Shares Outstanding, Diluted 385M shares +0.39%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 21.4B USD +9.94%
Cost of Revenue 7.78B USD +7.45%
Research and Development Expense 1.43B USD +4.29%
Operating Income (Loss) 4.21B USD +26.8%
Nonoperating Income (Expense) -195M USD -16.8%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest 4.02B USD +27.3%
Income Tax Expense (Benefit) 568M USD +27.4%
Net Income (Loss) Attributable to Parent 3.45B USD +27.3%
Earnings Per Share, Basic 9.07 USD/shares +26.9%
Earnings Per Share, Diluted 8.97 USD/shares +26.7%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 1.87B USD +33.8%
Accounts Receivable, after Allowance for Credit Loss, Current 3.62B USD +11.1%
Inventory, Net 5.04B USD +9.82%
Assets, Current 11.6B USD +14.7%
Deferred Income Tax Assets, Net 1.61B USD +11.6%
Property, Plant and Equipment, Net 3.32B USD +7.66%
Operating Lease, Right-of-Use Asset 510M USD +6.03%
Intangible Assets, Net (Excluding Goodwill) 4.36B USD -11.3%
Goodwill 15.4B USD +1.56%
Other Assets, Noncurrent 2.79B USD +5.36%
Assets 39.1B USD +4.6%
Employee-related Liabilities, Current 887M USD -4.52%
Liabilities, Current 6.93B USD +5.19%
Accrued Income Taxes, Noncurrent 350M USD -25.4%
Deferred Income Tax Liabilities, Net 63M USD -5.97%
Operating Lease, Liability, Noncurrent 379M USD +4.41%
Other Liabilities, Noncurrent 1.97B USD +6.45%
Liabilities 19.4B USD -3.39%
Accumulated Other Comprehensive Income (Loss), Net of Tax -355M USD -7.58%
Retained Earnings (Accumulated Deficit) 17.8B USD +14.5%
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest 19.8B USD +13.8%
Liabilities and Equity 39.1B USD +4.6%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities 204M USD -54.2%
Net Cash Provided by (Used in) Financing Activities -418M USD +13.1%
Net Cash Provided by (Used in) Investing Activities -408M USD -209%
Common Stock, Shares Authorized 1B shares 0%
Common Stock, Par or Stated Value Per Share 0.1 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -641M USD -271%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 1.87B USD +33.8%
Deferred Tax Assets, Valuation Allowance 223M USD -21.8%
Deferred Tax Assets, Gross 2.89B USD +6.53%
Depreciation 107M USD +11.5%
Payments to Acquire Property, Plant, and Equipment 167M USD +28.5%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent 3.42B USD +28.4%
Property, Plant and Equipment, Gross 6.62B USD +8.79%
Operating Lease, Liability, Current 143M USD +14.4%
Lessee, Operating Lease, Liability, to be Paid, Year Two 108M USD +12.5%
Lessee, Operating Lease, Liability, to be Paid, Year One 150M USD +19%
Operating Lease, Weighted Average Discount Rate, Percent 0.04 pure 0%
Deferred Income Tax Expense (Benefit) -39M USD -1200%
Lessee, Operating Lease, Liability, to be Paid, Year Three 87M USD +19.2%
Deferred Tax Assets, Operating Loss Carryforwards 385M USD +55.9%
Preferred Stock, Shares Authorized 500K shares 0%
Unrecognized Tax Benefits 371M USD +29.7%
Lessee, Operating Lease, Liability, to be Paid, Year Four 56M USD +3.7%
Preferred Stock, Shares Outstanding 0 shares
Amortization of Intangible Assets 621M USD -2.82%
Deferred Tax Assets, Net of Valuation Allowance 2.67B USD +9.85%
Preferred Stock, Par or Stated Value Per Share 1 USD/shares 0%